Nassau, Bahamas - April 3, 2024- Oceanside Treatment Center Bahamas is thrilled to announce the establishment of its groundbreaking Research and Development Department, dedicated to advancing the understanding and application of Ibogaine and Psilocybin therapies. Leading this pioneering initiative is Gina Honek, Clinical Director of Research and Development, renowned for her expertise in Ibogaine treatment and Psilocybin assisted therapies. Ibogsine known for its profound effects on the brain, ability to change neuroplasticity, detoxification , and addiction interruption , offer promising avenues for addressing addiction and mental health challenges. Ibogaine, in particular, has shown remarkable potential in disrupting addictive patterns and facilitating transformative experiences. Through our newly formed department, we are committed to conducting internal studies, leveraging the insights gained from patients undergoing therapy to inform our research endeavors.

"Our mission at Oceanside Treatment Center Bahamas is to push the boundaries of treatment innovation," says Gina Honek, Clinical Director of Research and Development. "By delving into the mechanisms of Ibogaine and Psilocybin and their impact on the brain, we aim to unlock new pathways for healing and recovery."

The implications of our research extend far beyond our clinic's walls. As the opioid epidemic continues to ravage communities worldwide and mental health challenges like depression, anxiety, and PTSD remain prevalent, our studies hold the promise of transformative solutions. By harnessing the therapeutic potential of Ibogaine and Psilocybin, we envision a future where individuals battling addiction and mental health disorders find hope and healing.

Oceanside Treatment Center Bahamas invites collaboration and dialogue with fellow researchers, practitioners, and advocates who share our commitment to innovation and compassionate care. Together, we can pioneer a new era of treatment modalities that redefine the landscape of addiction and mental health care.

For media inquiries or to learn more about our research initiatives, please contact:
Oceanside Treatment Center Bahamas:
1-800-846-0038
www.oceansideibogaine.com